Matthias Lenfant

Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center

Michiel Bronswijk, Annick Moens, Matthias Lenfant et al. · Inflammatory Bowel Diseases · 2019 · 20 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study

An Outtier, Édouard Louis, Olivier Dewit et al. · Clinical Gastroenterology and Hepatology · 2024 · 16 citations · Full text

Life Sciences, Clinical Sciences, Immunology +6

The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long‐term clinical outcomes in patients with ulcerative colitis

Matthias Lenfant, Matthias Lenfant, Bram Verstockt et al. · Alimentary Pharmacology & Therapeutics · 2023 · 15 citations

Medicine, Clinical Sciences, Internal Medicine +17

Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis

S Deleu, Inge Jacobs, Jorge Francisco Vazquez Castellanos et al. · Nutrients · 2024 · 13 citations · Full text

Life Sciences, Immunology, Microbiology +16

Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study

Geert D’Haens, Mark Löwenberg, Filip Baert et al. · ˜The œLancet. Gastroenterology & hepatology · 2025 · 10 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15